Skip to main content
SpringerLink
Log in

Immunobiology of complete molar pregnancy and gestational trophoblastic tumor

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

The unique curability of gestational trophoblastic tumors may in part be attributable to a host immunologic response. The occurrence of rapidly progressive and fatal choriocarcinoma may be favored by histocompatibility between patients and their partners. However, histocompatibility is not a prerequisite for the development and persistence of gestational choriocarcinoma. The expression of HLA by choriocarcinomateins in culture is enhanced following incubation with gamma-interferon and this may be of both biologic and clinical significance. Complete molar pregnancy is a complete allograft because all molar chromosomes are of paternal origin. Patients with complete mole are sensitized to paternal HLA antigen which is expressed in molar tissue. Other polymorphic antigen systems including trophoblast-leukocyte common antigens and placental-type alkaline phosphatase are also expressed in molar tissue. We have studied the immunopathology of the molar implantation site to investigate possible humoral and cellular immune responses. The Relationships among normal placenta, complete mole and choriocarcinoma are not clearly understood. The sattern of expression of oncofetal antigens in these three gestational tissues may be used to assess trophoblastic differentiation. In studies to date, molar trophoblast has the same pattern of expression of oncofetal antigens as normal placental trophoblast. We will review recent advances in our understanding of the immunobiology of gestational trophoblastic disease and suggest new directions for further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bagshawe KD: Choriocarcinoma. Edward Arnold Ltd, London, 1969

    Google Scholar 

  2. Goldstein DP, Berkowitz RS: Gestational trophoblastic neoplasms: clinical principles of diagnosis and management. W.B. Saunders, Philadelphia, 1982

    Google Scholar 

  3. Li MC, Hertz R, Spencer DB: Effect of methotrexate therapy on choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med (93) 361–366, 1956

    Google Scholar 

  4. Berkowitz RS, Goldstein DP, Bernstein MR: Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol (23): 111–118, 1986

    Google Scholar 

  5. Elston CW: Cellular reaction to choriocarcinoma. J Path (97) 261–268, 1969

    Google Scholar 

  6. Deligdisch L, Driscoll SG, Goldstein DP: Gestational trophoblastic neoplasms: morphologic correlates of therapeutic response. Am J Obstet Gynecol (130) 801–806, 1978

    Google Scholar 

  7. Ito S, Sekine T, Komuro N, Tanaka T, Yokoyama S, Hosokawa T: Histologic stromal reaction of the host with gestational choriocarcinoma and its relation to clinical stage classification and prognosis. Am J Obstet Gynecol (140) 781–786, 1981

    Google Scholar 

  8. Cinander B, Hayley MA, Rider WD, Warwick OH: Immunotherapy of a patient with choriocarcinoma. Canad M A J (84) 306–309, 1961

    Google Scholar 

  9. Kajii T, Ohama K: Androgenetic origin of hydatidiform mole. Nature (London) (268) 633–634, 1977

    Google Scholar 

  10. Wake N, Takagi N, Sasaki M: Androgenesis as a cause of hydatidiform mole. J Nat Cancer Inst (60) 51–53, 1978

    Google Scholar 

  11. Lawler SD, Pickthall VJ, Fisher RA, Povery S, Evans MW, Szulman AE: Genetic studies of complete and partial hydatidiform moles. Lancet(ii) 580, 1979

    Google Scholar 

  12. Yamashita K, Wake N, Araki T, Ichinoe K, Makoto K: Human lymphocyte antigen expression in hydatidiform mole: Androgenesis following fertilization by a haploid sperm. Am J Obstet Gynecol (135) 597–600, 1979

    Google Scholar 

  13. Jacobs PA, Wilson CM, Sprenkle JA, Rosenshein NB, Migeon BR: Mechanism of origin of complete hydatidiform moles. Nature (London) (286) 714–716, 1980

    Google Scholar 

  14. Surti U, Szulman AE, O'Brien S: Complete (classic) hydatidiform mole with 46,XY karyotype of paternal origin. Hum Genet (51) 153–155, 1979

    Google Scholar 

  15. Pattillo RA, Sasaki S, Katayama KP, Roesler M, Mattingly RF: Genesis of 46,XY hydatidiform mole. Am J Obstet Gynecol (141) 104–105, 1981

    Google Scholar 

  16. Berkowitz RS, Sandstrom M, Goldstein DP, Driscoll SG: 45,X Complete hydatidiform mole. Gynecol Oncol (41) 279–283, 1982

    Google Scholar 

  17. Wake N, Seki T, Fujita H, Okubo H, Sakai K, Okuyama K, Hayashi H, Shiina HJ, Sato H, Kuroda M, Ichinoe K: Malignant potential of homozygous and heterozygous complete moles. Cancer Res (44) 1226–1230, 1984

    Google Scholar 

  18. Wake N, Tanaka K, Chapman V, Matsui S, Sandberg AA: Chromosomes and cellular origin of choriocarcinoma. Cancer Res (41) 3137–3143, 1981

    Google Scholar 

  19. Davis JR, Surwit EA, Garay JP, Fortier KJ: Sex assignment in gestational trophoblastic neoplasia. Am J Obstet Gynecol (148) 722–725, 1984

    Google Scholar 

  20. Sasaki S, Katayama PK, Roesler M, Pattillo RA, Mattingly RF, Ohkawa K: Cytogenetic analysis of choriocarcinoma cell lines. Acta Obstet Gynaecol Jpn (34) 2253–2256, 1982

    Google Scholar 

  21. Fisher RA and Lawler SD: Heterozygous complete hydatidiform moles: do they have a worse prognosis than homozygous complete moles? Lancet (2) 51, 1984

    Google Scholar 

  22. Berkowitz RS, Mostoufizadeh M, Kabawat SE, Goldstein DP, Driscoll SG: Immunopathologic study of the implantation site in molar pregnancy. Am J Obstet Gynecol (144) 925–930, 1982

    Google Scholar 

  23. Kabawat SE, Mostoufi-Zadeh M, Berkowitz RS, Driscoll SG, Goldstein DP, Bhan AK: Implantation site in complete molar pregnancy: A study of immunologically competent cells with monoclonal antibodies. Am J Obstet Gynecol (152) 97–99, 1985

    Google Scholar 

  24. Bhan AK, MihmJr MC, Dvorak HF: T-cell subsets in allograft rejection: In-situ characterization of T-cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol (129) 1578–1583, 1982

    Google Scholar 

  25. Berkowitz RS, Lahey SJ, Rodrick ML, Rayner AA, Goldstein DP, Steele GJr: Circulating immune complex levels in patients with molar pregnancy. Obstet Gynecol (61) 165–168, 1983

    Google Scholar 

  26. Abbas AK, Klaus GGB: Antigen-antibody complexes suppress antibody production by mouse plasmacytoma cells in vitro. Eur J Immunol (8) 217–220, 1978

    Google Scholar 

  27. Caulfield MJ, Luce KJ, Proffitt MR, Cerny J: Induction of idiotype-specific suppressor T cells with antigen/antibody complexes. J Exp Med (157) 1713–1725, 1983

    Google Scholar 

  28. Rouzer CA, Scott WA, Hamill AL, Liu FT, Katz DH, Cohn ZA: Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin immune complexes. J Exp Med (156) 1077–1086, 1982

    Google Scholar 

  29. Lahey SJ, SteeleJr G, Rodrick ML, Berkowitz RS, Goldstein DP, Ross DS, Ravikumar TS, Wilson RE, Byrn R, Thomas P, Zamcheck N: Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia. Cancer (53) 1316–1321, 1984

    Google Scholar 

  30. Lawler SD, Klouda PT, Bagshawe KD: Immunogenicity of molar pregnancies in the HLA system. Am J Obstet Gynecol (120) 857–861, 1974

    Google Scholar 

  31. Yamashita K, Wake N, Araki T, Ichinoe K, Kuroda M: A further HLA study of hydatidiform moles. Gynecol Oncol (11) 23–28, 1981

    Google Scholar 

  32. Berkowitz RS, Anderson DJ, Hunter NJ, Goldstein DP: Distribution of major histocompatibility (HLA) antigens in chorionic villi of molar pregnancy. Am J Obstet Gynecol (146) 221–222, 1983

    Google Scholar 

  33. Sunderland CA, Redman CWG, Stirrat GM: Characterization and localization of HLA antigens on hydatidiform mole. Am J Obstet Gynecol (151) 130–135, 1985

    Google Scholar 

  34. Faulk WP, Temple A: Distribution of beta-2 microglobulin and HLA in chorionic villi of human placentae. Nature (262) 799–802, 1976

    Google Scholar 

  35. Sunderland CA, Redman CWG, Stirrat GM: HLA-ABC antigens are expressed on non-villous trophoblast of the early human placenta. J Immunol (127) 2614–2615, 1981

    Google Scholar 

  36. Berkowitz RS, Hoch EJ, Goldstein DP, Anderson DJ: Histocompatibility antigens (HLA-ABC) are not detectable in molar villous fluid. Gynecol Oncol (19) 74–78, 1984

    Google Scholar 

  37. Shaw ARE, Dasgupta MK, Kovithavongs T, Johny KV, LeRiche JL, Dossetor JB, McPherson TA: Humoral and cellular immunity to paternal antigens in trophoblastic neoplasia. Int J Cancer (24) 586–593, 1979

    Google Scholar 

  38. Lahey SJ, SteeleJr G, Berkowitz RS, Rodrick ML, Ross DS, Goldstein DP, Zamcheck N, Wilson RE, Deasy JM: Indentification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia. J Nat Cancer Inst (72) 983–990, 1984

    Google Scholar 

  39. Sasagawa M, Kajino T, Kanazawa K, Takeuchi S: Immunohistochemical study on subpopulations of trophoblasts in normal pregnancy and hydatidiform mole. Proceedings of the Second World Congress on Trophoblastic Neoplasms (abstract) p. 13, 1984

  40. Trowsdale J, Travers P, Bodmer WF, Pattillo RA: Expression of HLA-ABC and beta-2 microglobulin antigens in human choriocarcinoma cell lines. J Exp Med (152) 11S-17S, 1980

    Google Scholar 

  41. Kawata M, Parnes JR, Herzenberg LA: Transcriptional control of HLA-ABC antigen in human placental cytotrophoblast isolated using trophoblast- and HLA-specific monoclonal antibodies and the fluorescence-activated cell sorter. J Exp Med (160) 633–651, 1984

    Google Scholar 

  42. Anderson DJ, Berkowitz RS: Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA-positive human choriocarcinoma cell line BeWo but does not induce MHC expression in the HLA-negative choriocarcinoma cell line. Jar J Immunol (135) 2498–2501, 1985

    Google Scholar 

  43. Heron I, Hokland M, Berg K: Enhanced expression of beta 2 microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci USA (77) 6215–6219, 1978

    Google Scholar 

  44. Fellous M, Nir V, Wallach D, Merlin G, Rubenstein M, Revel M: Interferon dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts. Proc Natl Acad Sci USA (79) 3082–3086, 1982

    Google Scholar 

  45. Morgensen B, Kissmeyer-Nielsen F, Hauge M: Histocompatibility antigens on the HLA locus in gestational choriocarcinoma. Transplant Proc (1) 76–80, 1969

    Google Scholar 

  46. Tomoda Y, Fuma M, Saiki N, Ishizuka N, Akaza T: Immunologic studies in patients with trophoblastic neoplasia. Am J Obstet Gynecol (126) 661–667, 1976

    Google Scholar 

  47. Berkowitz RS, Hornig-Rohan J, Martin-Alosco S, Klein S, Goldstein DP, BastJr RC, DeWolf WC: HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbands. Placenta Suppl (3) 263–267, 1981

    Google Scholar 

  48. Klouda PT, Lawler SD, Bagshawe KD: HL-A matings in trophoblastic neoplasia. Tissue Antigens (2) 280–284, 1972

    Google Scholar 

  49. Mittal KK, Kachru RB, Brewer JI: The HL-A and ABO antigens in trophoblastic disease. Tissue Antigens (6) 57–69, 1975

    Google Scholar 

  50. Yamashita K, Ishikawa M, Shimizu T, Kuroda M: HLA-antigens in husband-wife pairs with trophoblastic tumor. Gynecol Oncol (12) 68–74, 1981

    Google Scholar 

  51. Lawler SD, Klouda PT, Bagshawe KD: The HL-A system in trophoblastic neoplasia. Lancet (2) 834–837, 1971

    Google Scholar 

  52. LewisJr JL, Terasaki PI: HL-A leukocyte antigen studies in women with gestational trophoblastic neoplasms. Am J Obstet Gynecol (111) 547–552, 1971

    Google Scholar 

  53. Bulmer JN, Johnson PM: Antigen expression by trophoblast populations in the human placenta and their possible immunobiological relevance. Placenta (6) 127–140, 1985

    Google Scholar 

  54. Mc Intyre JA, Faulk WP, Verhulst SJ, Colliver JA: Human trophoblast-lymphocyte cross-reactive (TLX) antigens define a new alloantigen system. Science (222) 1135–1137, 1983

    Google Scholar 

  55. Mc Laughlin PJ, Cheng HM, Slade MB, Johnson PM: Expression on cultured human tumour cells of placental trophoblast membrane antigens and placental alkaline phosphatase defined by monoclonal antibodies. Int J Cancer (30) 21–26, 1982

    Google Scholar 

  56. Berkowitz RS, Umpierre S, Johnson PM, McIntyre J, Anderson DJ: Expression of trophoblast-leukocyte common antigens and placental-type alkaline phosphatase in complete molar pregnancy. Am J Obstet Gynecol (155) 443–446, 1986

    Google Scholar 

  57. Faulk WP, Temple A, Lovins RE, Smith N: Antigens of human trophoblasts: A working hypothesis for their role in normal and abnormal pregnancy. Proc Natl Acad Sci USA (75) 1947–1951, 1978

    Google Scholar 

  58. Hercend T, Griffin JD, Bensussan A, Schmidt RE, Edson MA, Brennan A, Murray C, Daley JF, Schlossman SF, Ritz J: Generation of monoclonal antibodies to a human natural killer clone. J Clin Invest (75) 932–943, 1985

    Google Scholar 

  59. Nedwin GE, Sverdersky LP, Bringman MA, Palladino MA, Goeddel DV: Effect of interleukin 2, interferon and mitogens on the production of tumor necrosis factor alpha and beta. J Immunol (135) 2492–2497, 1985

    Google Scholar 

  60. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ: Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol (135) 3962–3968, 1985

    Google Scholar 

  61. Mehta SR, Conrad D, Sandler R, Morgan J, Montagna R, Maizel AL: Putification of human B-cell growth factor. J Immunol (135) 3298–3302, 1985

    Google Scholar 

  62. Tsujimoto M, Yip YK, Vilcek J: Gamma interferon enhances expression of cellular receptors for tumor necrosis factor. J Immunol (136) 2441–2444, 1986

    Google Scholar 

  63. Garland JM: Growth, receptors, and interleukin-3. Immunol Today (7) 104–107, 1986

    Google Scholar 

  64. Glasgow AM, Nimberg RB, Menzoian R: Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. NEJM (291) 1263–1268, 1979

    Google Scholar 

  65. Hess AD, Gall SA, Dawson JR: Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients. Cancer Res (39) 2381–2391, 1979

    Google Scholar 

  66. Roth JA, Osborne BA, Ames RS: Immunoregulatory factors derived from human tumors. J Immunol (130) 303–308, 1983

    Google Scholar 

  67. Remacle-Bonnet MM, Pommer GJ, Kaplanski S, Rance RJ, Depides RC: Inhibition of normal allogeneic lymphocyte mitogenesis by soluble inhibitor extracted from human colonic carcinoma. J Immunol (117) 1145–1151, 1976

    Google Scholar 

  68. Renk CM, Gupta RK, Morton DH: Inhibition of normal allogeneic lymphocyte mitogenesis by a factor released by human tumor cells in culture. Cancer Immunol Immunother (11) 7–12, 1981

    Google Scholar 

  69. Hamoaka T, Matsuzuki N, Itoh K, Tsuju Y, Izumi Y, Fujiwara H, Ono S: Human trophoblast and tumor cell derived immunoregulatory factors. In: Isojima S, Billington WD (eds) Reproductive immunology. Elsevier Science Publishers, Amsterdam, 1983, pp 133–142

    Google Scholar 

  70. Wolf RL, Ilekis J, Benveniste R: Characterization of an immune suppressor from transformed human trophoblastic JEG-3 cells. Cell Immunol (78) 356–367, 1983

    Google Scholar 

  71. Vlasselaer VP, Vandeputte M: Immunosuppressive properties of murine trophoblast. Cell Immunol (83) 422–432. 1984

    Google Scholar 

  72. Chaoat G, Kolg JP: Immunoactive products of placenta IV. J Immunol (135) 215–222, 1985

    Google Scholar 

  73. Sinigaglia F, Talmadge KW: Inhibition of thymidine incorporation by mycoplasma arginini-infected cells due to enzymatic cleavage of the nucleoside. Eur J Immunol (15) 692–696, 1985

    Google Scholar 

  74. Berkowitz RS, Goldstein DP: Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Ann (11) 391–411, 1981

    Google Scholar 

  75. Kato M, Tanaka K, Takeuchi S: The nature of trophoblastic disease initiated by transplantation into immunosuppressed animals. Am J Obstet Gynecol (142) 497–505, 1982

    Google Scholar 

  76. Takeuchi S: Immunology of spontaneous abortion. Am J Reprod Immunol (1) 23–28, 1980

    Google Scholar 

  77. Saksela O, Wahlstrom T, Lehtovirta P, Seppala M, Vaheri A: Presence of alpha 2-macroglobulin in normal but not malignant human syncytiotrophoblasts. Cancer Res (41) 2507–2513, 1981

    Google Scholar 

  78. Seppala M, Wahlstrom T, Bohn H: Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: Absence of PP5 expression in the malignant trophoblast. Int J Cancer (24) 6–10, 1979

    Google Scholar 

  79. Loke YW, Whyte A, Davies SP: Differential expression of trophoblast-specific membrane antigens by normal and abnormal human placentae and by neoplasms of trophoblastic and non-trophoblastic origin. Int J Cancer (25) 459–461, 1980

    Google Scholar 

  80. Berkowitz RS, AlbertiJr O, Hunter NJ, Goldstein DP, Anderson DJ: Localization of stage-specific embryonic antigens in hydatidiform mole, normal placenta and gestational choriocarcinoma. Gynecol Oncol (20) 71–77, 1985

    Google Scholar 

  81. Berkowitz RS, Alexander NJ, Goldstein DP, Anderson DJ: Reactivity of antihuman sperm monoclonal antibodies with normal placenta, hydatidiform mole and gestational choriocarcinoma. Gynecol Oncol (22) 334–340, 1985

    Google Scholar 

  82. Solter D, Knowles BB: Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1) Proc Natl Acad Sci USA (75) 5565–5569, 1978

    Google Scholar 

  83. Fox N, Damjanov I, Knowles BB, Solter D: Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res (43) 669–678, 1983

    Google Scholar 

  84. Shevinsky LH, Knowles BB, Damjanov I, Solter D: Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell (30) 697–705, 1982

    Google Scholar 

  85. Menge AC, Fleming CH: Detection of sperm antigens on mouse ova and early embryos. Develop Biol (63) 111–117, 1978

    Google Scholar 

  86. Anderson DJ, Adams PH, Hamilton MS, Alexander NJ: Antisperm antibodies in mouse vasectomy sera react with embryonal teratocarcinoma. J Immunol (131) 2908–2912, 1983

    Google Scholar 

  87. Hilkens J, Baijs F, Hilgers J, Hageman PH, Calafat J, Sonnenberg A, Van der Valk M: Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer (34) 197–206, 1984

    Google Scholar 

  88. BastJr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (68) 1331–1337, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brigham and Women's Hospital, 75 Francis Street, 12115, Boston, MA, U.S.A.

    Ross S. Berkowitz

Authors
  1. Ross S. Berkowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharee A. Umpierre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sherry Taylor-Emery
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donald P. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Deborah J. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Aearing Laboratory, New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Brigham and Women's Hospital, Department of Obstetrics and Gynecology, Harward Medical School

Supported by NIH grant CA42738.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berkowitz, R.S., Umpierre, S.A., Taylor-Emery, S. et al. Immunobiology of complete molar pregnancy and gestational trophoblastic tumor. Cancer Metast Rev 5, 109–123 (1986). https://doi.org/10.1007/BF00046426

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00046426

Keywords

Search

Navigation